Cuproptosis and Cu: a New Paradigm in Cellular Death and Their Role in Non-cancerous Diseases

Overview

Journal Apoptosis

Publisher Springer

Date 2024 Jul 16

PMID 39014119

Authors

Zhibo Yang

Ridong Feng

Hai Zhao

Affiliations

Soon will be listed here.

Abstract

Cuproptosis, a newly characterized form of regulated cell death driven by copper accumulation, has emerged as a significant mechanism underlying various non-cancerous diseases. This review delves into the complex interplay between copper metabolism and the pathogenesis of conditions such as Wilson's disease (WD), neurodegenerative disorders, and cardiovascular pathologies. We examine the molecular mechanisms by which copper dysregulation induces cuproptosis, highlighting the pivotal roles of key copper transporters and enzymes. Additionally, we evaluate the therapeutic potential of copper chelation strategies, which have shown promise in experimental models by mitigating copper-induced cellular damage and restoring physiological homeostasis. Through a comprehensive synthesis of recent advancements and current knowledge, this review underscores the necessity of further research to translate these findings into clinical applications. The ultimate goal is to harness the therapeutic potential of targeting cuproptosis, thereby improving disease management and patient outcomes in non-cancerous conditions associated with copper dysregulation.

Citing Articles

Investigating cuproptosis and mitochondrial dysfunction in brain cells: uncovering novel mechanisms and biomarkers for Parkinson's disease.

Li Q, Li D, Li Y, Yang K, Ren Y Metab Brain Dis. 2025; 40(3):144.

PMID: 40072691 DOI: 10.1007/s11011-025-01574-1.

Copper in melanoma: At the crossroad of protumorigenic and anticancer roles.

Chrzan N, Hartman M Redox Biol. 2025; 81:103552.

PMID: 39970778 PMC: 11880738. DOI: 10.1016/j.redox.2025.103552.

A cellular danse macabre: the choreography of programmed cell death.

Griffioen A, Nowak-Sliwinska P Apoptosis. 2025; .

PMID: 39924582 DOI: 10.1007/s10495-025-02076-2.

Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease.

Mao Y, Chen H, Zhu W, Ni S, Luo S, Tang S J Inflamm Res. 2025; 18:883-894.

PMID: 39867947 PMC: 11760270. DOI: 10.2147/JIR.S498340.

Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition.

Yoo J, Lee J, Ahn B, Han J, Lim M Chem Sci. 2025; 16(5):2105-2135.

PMID: 39810997 PMC: 11726323. DOI: 10.1039/d4sc06762b.

References

Yang S, Li Y, Zhou L, Wang X, Liu L, Wu M . Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies. Cell Death Discov. 2024; 10(1):25. PMC: 10787750. DOI: 10.1038/s41420-023-01796-1. View

Pal I, Dey S . The Role of Heme and Copper in Alzheimer's Disease and Type 2 Diabetes Mellitus. JACS Au. 2023; 3(3):657-681. PMC: 10052274. DOI: 10.1021/jacsau.2c00572. View

Wang D, Tian Z, Zhang P, Zhen L, Meng Q, Sun B . The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomed Pharmacother. 2023; 163:114830. DOI: 10.1016/j.biopha.2023.114830. View

Roberts E, Schilsky M . Current and Emerging Issues in Wilson's Disease. N Engl J Med. 2023; 389(10):922-938. DOI: 10.1056/NEJMra1903585. View

Huang M, Zhang Y, Liu X . The mechanism of cuproptosis in Parkinson's disease. Ageing Res Rev. 2024; 95:102214. DOI: 10.1016/j.arr.2024.102214. View

Wang Q, Sun J, Chen T, Song S, Hou Y, Feng L . Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer's Disease. ACS Chem Neurosci. 2023; 14(19):3564-3587. DOI: 10.1021/acschemneuro.3c00343. View

Yang L, Yang P, Lip G, Ren J . Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends Pharmacol Sci. 2023; 44(9):573-585. DOI: 10.1016/j.tips.2023.07.004. View

Bandmann O, Weiss K, Kaler S . Wilson's disease and other neurological copper disorders. Lancet Neurol. 2014; 14(1):103-13. PMC: 4336199. DOI: 10.1016/S1474-4422(14)70190-5. View

Cao S, Wang Q, Sun Z, Zhang Y, Liu Q, Huang Q . Role of cuproptosis in understanding diseases. Hum Cell. 2023; 36(4):1244-1252. PMC: 10165592. DOI: 10.1007/s13577-023-00914-6. View

10.

Remiao F, Carmo H, Carvalho F, Bastos M . Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes: effects on oxidative stress. Cardiovasc Toxicol. 2002; 1(3):195-204. DOI: 10.1385/ct:1:3:195. View

11.

Kunutsor S, Dey R, Laukkanen J . Circulating Serum Copper Is Associated with Atherosclerotic Cardiovascular Disease, but Not Venous Thromboembolism: A Prospective Cohort Study. Pulse (Basel). 2022; 9(3-4):109-115. PMC: 8739646. DOI: 10.1159/000519906. View

12.

Brewer G . Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. J Cell Mol Med. 2003; 7(1):11-20. PMC: 6740133. DOI: 10.1111/j.1582-4934.2003.tb00198.x. View

13.

Ackerman C, Lee S, Chang C . Analytical Methods for Imaging Metals in Biology: From Transition Metal Metabolism to Transition Metal Signaling. Anal Chem. 2016; 89(1):22-41. PMC: 5827935. DOI: 10.1021/acs.analchem.6b04631. View

14.

Hare D, New E, de Jonge M, McColl G . Imaging metals in biology: balancing sensitivity, selectivity and spatial resolution. Chem Soc Rev. 2015; 44(17):5941-58. DOI: 10.1039/c5cs00055f. View

15.

Migocka M . Copper-transporting ATPases: The evolutionarily conserved machineries for balancing copper in living systems. IUBMB Life. 2015; 67(10):737-45. DOI: 10.1002/iub.1437. View

16.

Georgatsou E, Mavrogiannis L, Fragiadakis G, Alexandraki D . The yeast Fre1p/Fre2p cupric reductases facilitate copper uptake and are regulated by the copper-modulated Mac1p activator. J Biol Chem. 1997; 272(21):13786-92. DOI: 10.1074/jbc.272.21.13786. View

17.

Ramos D, Mar D, Ishida M, Vargas R, Gaite M, Montgomery A . Mechanism of Copper Uptake from Blood Plasma Ceruloplasmin by Mammalian Cells. PLoS One. 2016; 11(3):e0149516. PMC: 4774968. DOI: 10.1371/journal.pone.0149516. View

18.

Moschini E, Colombo G, Chirico G, Capitani G, Dalle-Donne I, Mantecca P . Biological mechanism of cell oxidative stress and death during short-term exposure to nano CuO. Sci Rep. 2023; 13(1):2326. PMC: 9911756. DOI: 10.1038/s41598-023-28958-6. View

19.

Moriya M, Ho Y, Grana A, Nguyen L, Alvarez A, Jamil R . Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism. Am J Physiol Cell Physiol. 2008; 295(3):C708-21. PMC: 2544443. DOI: 10.1152/ajpcell.00029.2008. View

20.

Liu N, Lo L, Askary S, Jones L, Kidane T, Trang T . Transcuprein is a macroglobulin regulated by copper and iron availability. J Nutr Biochem. 2007; 18(9):597-608. PMC: 4286573. DOI: 10.1016/j.jnutbio.2006.11.005. View